SCHEMBL1729127

SCHEMBL1729127

COCOc1c(O)cc(Br)cc1C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.37
ALOX15 P16050 4/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
ATP2A2 P16615 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ATP2A3 Q93084 1/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
EGFR P00533 1/20 0.32
ACLY P53396 1/20 0.31
NR1I2 O75469 1/20 0.31
CYP2C9 P11712 1/20 0.31
MIF P14174 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17291956 0.82 PTGDR2 (0.35) PTGDR2ALDH1A1KDM4ECYP1A2
SCHEMBL1729069 0.78 ALDH1A1 (0.41) PTGDR2ALDH1A1CYP1A2LMNA
SCHEMBL1729169 0.78 PTGDR2 (0.35) PTGDR2ALDH1A1CYP1A2MAPTSMN1; SMN2
SCHEMBL8807107 0.78 ALDH1A1 (0.39) ALOX15ALDH1A1KDM4ECYP1A2MAPT
SCHEMBL6920738 0.77 PTGDR2 (0.32) PTGDR2
SCHEMBL28734927 0.72 CA2 (0.46) ALDH1A1KDM4ECYP1A2MAPTCYP3A4
SCHEMBL6033258 0.72 ALDH1A1 (0.36) ALDH1A1CYP1A2EGFRCYP2C9
SCHEMBL5086986 0.72 CYP2D6 (0.38) ALDH1A1KDM4ECYP1A2MAPTSMN1; SMN2
SCHEMBL28734957 0.71 HTR2A (0.30)
SCHEMBL8779698 0.71 EGFR (0.48) ALDH1A1KDM4EMAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391451-B1 2-IMINOPYRROLIDINE DERIVATES EISAI R&D MAN CO LTD (JP) 2011-11-23 EP disclosed
CN-100402499-C 2-iminopyrrolidine derivatives EISAI CO LTD (JP) 2008-07-16 CN disclosed
US-7244730-B2 2-iminopyrrolidine derivatives EISAI CO., LTD (JP) 2007-07-17 US disclosed
US-7244730-B2 2-iminopyrrolidine derivatives EISAI CO., LTD (JP) 2007-07-17 US disclosed
US-7244730-B2 2-iminopyrrolidine derivatives EISAI CO., LTD (JP) 2007-07-17 US disclosed
CN-1321996-C Process for producing 2-iminopyrrolidine derivative SANITATION STUFF R & D MANAGE (JP) 2007-06-20 CN disclosed
CN-1754880-A Process for preparing 2-iminopyrrolidine derivatives EISAI CO LTD (JP) 2006-04-05 CN disclosed
CN-1243735-C 2-iminopyrrolidine derivatives EISAI CO LTD (JP) 2006-03-01 CN disclosed
CN-1733725-A Process for preparing 2-iminopyrrolidine derivatives EISAI CO LTD (JP) 2006-02-15 CN disclosed
US-20050245592-A1 2-Iminopyrrolidine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-03 US disclosed
US-20050004204-A1 2-Iminopyrrolidine derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-06 US disclosed
CN-1503784-A 2-iminopyrrolidine derivatives ������������ʽ���� 2004-06-09 CN disclosed
EP-1391451-A1 2-IMINOPYRROLIDINE DERIVATES Eisai Co., Ltd. (JP) 2004-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245592-A1 2-Iminopyrrolidine derivatives H1-2, H1-3, H1-0 PTGDR2 549/4885ALOX15 4389/4885ALDH1A1 443/4885
US-20050004204-A1 2-Iminopyrrolidine derivatives H1-2, H1-3, H1-0 PTGDR2 544/4885ALOX15 4395/4885ALDH1A1 437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.